Načítá se...
Plasma ApoA1 Associates with Age at Onset and Motor Severity in Early Parkinson Disease Patients
BACKGROUND: The development of robust plasma-based biomarkers in Parkinson disease (PD) could lead to new approaches for identifying those at risk for PD and developing novel therapies. Here we validate plasma Apolipoprotein A1 (ApoA1) as a correlate of age at onset and motor severity in PD. METHODS...
Uloženo v:
| Vydáno v: | Mov Disord |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609229/ https://ncbi.nlm.nih.gov/pubmed/26207725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26290 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|